BMP2 and cyst: Since BMP2 adverse outcomes are dose-dependent, we applied various concentrations of BMP2 up to human dose equivalent BMP2 (75 μg per defect, 1.5 mg/ml) in our rodent mandibular defect model to elicit adverse outcomes associated with high dose BMP2 such as adipogenic differentiation with cyst-like bone formation.